Clearstead Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
6,605
+3,790
+135% +$788K 0.01% 431
2026
Q1
$595K Sell
2,815
-2,702
-49% -$582K 0.01% 673
2025
Q4
$1.13M Buy
5,517
+1,315
+31% +$247K 0.01% 441
2025
Q3
$660K Sell
4,202
-121
-3% -$18.7K 0.01% 554
2025
Q2
$726K Buy
4,323
+1,627
+60% +$241K 0.01% 509
2025
Q1
$371K Sell
2,696
-14
-0.5% -$1.78K 0.01% 650
2024
Q4
$321K Buy
2,710
+990
+58% +$116K ﹤0.01% 697
2024
Q3
$190K Sell
1,720
-949
-36% -$99.2K ﹤0.01% 873
2024
Q2
$262K Buy
2,669
+1,470
+123% +$150K ﹤0.01% 729
2024
Q1
$118K Hold
1,199
0.01% 574
2023
Q4
$121K Hold
1,199
0.01% 552
2023
Q3
$104K Hold
1,199
0.01% 550
2023
Q2
$113K Buy
1,199
+13
+1% +$1.1K 0.01% 546
2023
Q1
$89.5K Buy
1,186
+6
+0.5% +$453 0.01% 528
2022
Q4
$90.7K Hold
1,180
0.01% 520
2022
Q3
$79K Hold
1,180
0.01% 516
2022
Q2
$62K Hold
1,180
﹤0.01% 576
2022
Q1
$67K Hold
1,180
﹤0.01% 631
2021
Q4
$61K Sell
1,180
-2,779
-70% -$136K ﹤0.01% 621
2021
Q3
$196K Buy
3,959
+55
+1% +$2.98K 0.01% 371
2021
Q2
$223K Sell
3,904
-76
-2% -$4.44K 0.02% 328
2021
Q1
$242K Buy
3,980
+1,000
+34% +$55.2K 0.02% 308
2020
Q4
$160K Buy
2,980
+1,500
+101% +$77.8K 0.01% 346
2020
Q3
$69K Hold
1,480
0.01% 418
2020
Q2
$77K Buy
+1,480
New +$76.3K 0.01% 382

Other funds holding CAH

Clearstead Advisors's CAH Position: Q2 2026 in Review

Clearstead Advisors increased its Cardinal Health (CAH) stake by 135% in Q2 2026, buying an estimated $788K and bringing the position to 6,605 shares worth $1.57M. The position accounts for 0.01% of the portfolio, ranked #431.

Clearstead Advisors first reported a position in CAH in Q2 2020 and has held it in 25 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Clearstead Advisors held 6,605 shares of Cardinal Health worth $1.57M as of Q2 2026.
  • Clearstead Advisors bought 3,790 Cardinal Health shares in Q2 2026, an estimated $788K.
  • Cardinal Health made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #431 holding.
  • Clearstead Advisors first reported a position in Cardinal Health in Q2 2020 and has held it in 25 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.